ANI PHARMACEUTICALS INC
Ticker: 1023024
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 237.46+4.2% | 227.81+7.8% | 211.37+7.2% | 197.12+32.9% | 148.33+7.5% | 138.04+0.4% | 137.43+4.2% | 131.83 |
| Total Income | 237.46+4.2% | 227.81+7.8% | 211.37+7.2% | 197.12+32.9% | 148.33+7.5% | 138.04+0.4% | 137.43+4.2% | 131.83 |
| EXPENSES | ||||||||
| Expenditure | 198.57+3.7% | 191.57-3.0% | 197.48+15.5% | 170.93+1.2% | 168.85+27.1% | 132.87+13.4% | 117.12+2.8% | 113.88 |
| Tax | 10.73+49.4% | 7.18+262.6% | 1.98-54.1% | 4.31+158.8% | -7.33 | 0.00-100.0% | 7.13+354.1% | 1.57 |
| PROFIT | ||||||||
| PBT | 40.22+19.0% | 33.80+221.0% | 10.53-47.3% | 19.99+163.5% | -31.50-1275.5% | -2.29-109.0% | 25.34+120.2% | 11.51 |
| Net Profit | 29.49+10.8% | 26.62+211.3% | 8.55-45.5% | 15.68+164.9% | -24.17-955.5% | -2.29-112.6% | 18.21+83.2% | 9.94 |
| KEY METRICS | ||||||||
| OPM % | 16.38%+0.47pp | 15.91%+9.34pp | 6.57%-6.72pp | 13.29%+27.12pp | -13.83%-17.58pp | 3.75%-11.04pp | 14.78%+1.16pp | 13.62% |
| NPM % | 12.42%+0.74pp | 11.68%+7.64pp | 4.04%-3.91pp | 7.96%+24.25pp | -16.29%-14.64pp | -1.66%-14.90pp | 13.25%+5.71pp | 7.54% |
| EPS | 1.31+10.1% | 1.19+221.6% | 0.37-47.1% | 0.70+155.1% | -1.27-807.1% | -0.14-116.7% | 0.84+82.6% | 0.46 |
Corporate Events
Board MeetingANIP
202621May
Board Meeting
2026 Annual Meeting of Stockholders held to elect directors,…
SEC Filing ↗